MetaCap

Maze Therapeutics (MAZE) News

NASDAQ: MAZEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

31.37-1.06 (-3.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MAZE news summary

We found 3 recent headlines mentioning Maze Therapeutics (MAZE): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Seeking Alpha. For price context, MAZE is down 3.27% at $31.37. The most recent story, "Maze Therapeutics GAAP EPS of -$0.79", was published by Seeking Alpha on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Maze Therapeutics headlines

Compare MAZE